Our cell engineering capabilities are central to Laverock's mission to unlock the full potential of our gene control technology
Our highly efficient, automated cell engineering platform is agnostic to editing technology and cell type, providing high quality pooled and clonal cell lines for functional characterisation. Paired with our genotyping technology we can deliver maximum throughput with shortened timelines.
Highly efficient gene editing across a broad range of tools (e.g., nucleases), cell types (e.g., adherent, suspension, iPSC), and targets. The platform is designed to adapt quickly to new biological questions and project needs.
Automated, high-throughput workflows enable rapid generation and screening of large cell libraries, supporting projects from early discovery to scale-up. The platform accelerates timelines while maintaining performance across increased experimental demands.
Rigorous lab standards and fully digital tracking ensure experimental reproducibility, sample integrity, and transparent process documentation throughout the workflow.
Engineered cells retain critical characteristics, including iPSC identity or lineage-specific traits, across replicates and experiments. Standardized protocols and automation reduce variability, ensuring reliable performance and repeatable results.
Our RNA screening platform’s scalability and efficiency is highlighted by the case study below, showcasing how a pooled approach to RNA screening, using our scalable, efficient platform speeds up the discovery process, through high-throughput, data-driven RNA design evaluation.
Traditional arrayed screening requires individual RNA design, limited throughput and slowing down discovery.
We transitioned to pooled screening, enabling:
